Anavex Life Sciences Corp. (AVXL)

Anavex Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	138.76	151.02	149.16	152.11	29.25	22.19
Cash & Short-Term Investments	138.76	151.02	149.16	152.11	29.25	22.19
Cash Growth	-10.37%	1.25%	-1.94%	420.04%	31.84%	-3.25%
Other Receivables	1.72	2.71	3.19	9.14	4.85	2.64
Receivables	1.72	2.71	3.19	9.14	4.85	2.64
Prepaid Expenses	1.06	0.65	0.35	0.37	0.44	0.5
Total Current Assets	141.54	154.39	152.71	161.62	34.54	25.33
Total Assets	141.54	154.39	152.71	161.62	34.54	25.33
Accounts Payable	3.5	4.32	3.83	4.74	3.99	3.52
Accrued Expenses	7.33	7.3	5.95	5.61	3.32	1.52
Current Unearned Revenue	0.92	0.92	0.44	0.44	-	-
Total Current Liabilities	11.75	12.53	10.21	10.8	7.31	5.04
Total Liabilities	11.75	12.53	10.21	10.8	7.31	5.04
Common Stock	0.09	0.08	0.08	0.08	0.06	0.05
Additional Paid-In Capital	454.24	434.84	387.98	348.33	186.85	153.63
Retained Earnings	-324.45	-293.07	-245.56	-197.59	-159.68	-133.4
Comprehensive Income & Other	-0.09	-	-	-	-	-
Shareholders' Equity	129.78	141.85	142.49	150.82	27.24	20.29
Total Liabilities & Equity	141.54	154.39	152.71	161.62	34.54	25.33
Net Cash (Debt)	138.76	151.02	149.16	152.11	29.25	22.19
Net Cash Growth	-10.37%	1.25%	-1.94%	420.04%	31.84%	-3.25%
Net Cash Per Share	1.68	1.89	1.94	2.18	0.50	0.45
Filing Date Shares Outstanding	84.8	82.09	77.96	76.02	66.96	56.12
Total Common Shares Outstanding	84.8	82.07	77.94	75.92	62.05	52.65
Working Capital	129.78	141.85	142.49	150.82	27.24	20.29
Book Value Per Share	1.53	1.73	1.83	1.99	0.44	0.39
Tangible Book Value	129.78	141.85	142.49	150.82	27.24	20.29
Tangible Book Value Per Share	1.53	1.73	1.83	1.99	0.44	0.39

Source: S&P Capital IQ. Standard template. Financial Sources.